<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONDENSED FINANCIAL STATEMENTS OF T CELL SCIENCES, INC. FOR THE SIX MONTHS ENDED JUNE 30, 1997 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <CURRENCY> U.S. DOLLARS <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> DEC-31-1997 <PERIOD-START> JAN-01-1997 <PERIOD-END> JUN-30-1997 <EXCHANGE-RATE> 1 <CASH> 10,671,300 <SECURITIES> 0 <RECEIVABLES> 17,600 <ALLOWANCES> 0 <INVENTORY> 0 <CURRENT-ASSETS> 10,963,400 <PP&E> 3,083,100 <DEPRECIATION> (2,639,600) <TOTAL-ASSETS> 13,385,200 <CURRENT-LIABILITIES> 1,379,900 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 25,000 <OTHER-SE> 11,980,300 <TOTAL-LIABILITY-AND-EQUITY> 13,385,200 <SALES> 1,300 <TOTAL-REVENUES> 756,700 <CGS> 400 <TOTAL-COSTS> 4,688,500 <OTHER-EXPENSES> 17,900 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> (333,700) <INCOME-PRETAX> (3,616,400) <INCOME-TAX> 0 <INCOME-CONTINUING> (3,616,400) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (3,616,400) <EPS-PRIMARY> (0.14) <EPS-DILUTED> (0.14)